SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-16-000208
Filing Date
2016-08-04
Accepted
2016-08-04 16:22:05
Documents
63
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-6301610q.htm 10-Q 1062562
2 EXHIBIT 31.1 lgnd_63016exhibit311.htm EX-31.1 16493
3 EXHIBIT 31.2 lgnd_63016exhibit312.htm EX-31.2 16390
4 EXHIBIT 32.1 lgnd_63016exhibit321.htm EX-32.1 15612
  Complete submission text file 0000886163-16-000208.txt   7372225

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lgnd-20160630.xml EX-101.INS 1647125
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20160630.xsd EX-101.SCH 53065
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20160630_cal.xml EX-101.CAL 101584
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20160630_def.xml EX-101.DEF 264865
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20160630_lab.xml EX-101.LAB 831248
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20160630_pre.xml EX-101.PRE 445064
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 161807781
SIC: 2834 Pharmaceutical Preparations